[ppt] descriptive and analytical epidemiology

Views:
 
Category: Education
     
 

Presentation Description

[PPT] Descriptive and Analytical Epidemiology

Comments

Presentation Transcript

Public Health Information Network (PHIN) Series I :

Public Health Information Network (PHIN) Series I is for Epi Epidemiology basics for non-epidemiologists

Series Overview:

Series Overview Introduction to: The history of Epidemiology Specialties in the field Key terminology, measures, and resources Application of Epidemiological methods

Series I Sessions:

Series I Sessions Title Date “Epidemiology in the Context of Public Health” January 12 “An Epidemiologist’s Tool Kit” February 3 “Descriptive and Analytic Epidemiology” March 3 “Surveillance” April 7 “Epidemiology Specialties Applied” May 5

What to Expect. . . :

What to Expect. . . Today Understand the basic terminology and measures used in descriptive and analytic Epidemiology

Session I – V Slides:

Session I – V Slides VDH will post PHIN series slides on the following Web site: http://www.vdh.virginia.gov/EPR/Training.asp NCCPHP Training Web site: http://www.sph.unc.edu/nccphp/training

Site Sign-in Sheet:

Site Sign-in Sheet Please submit your site sign-in sheet to: Suzi Silverstein Director, Education and Training Emergency Preparedness & Response Programs FAX: (804) 225 - 3888

Series I Session III:

Series I Session III “Descriptive and Analytic Epidemiology”

Today’s Presenter:

Today’s Presenter Kim Brunette, MPH Epidemiologist North Carolina Center for Public Health Preparedness, Institute for Public Health, UNC Chapel Hill

Session Overview:

Session Overview Define descriptive epidemiology Define incidence and prevalence Discuss examples of the use of descriptive data Define analytic epidemiology Discuss different study designs Discuss measures of association Discuss tests of significance

Today’s Learning Objectives:

Today’s Learning Objectives Understand the distinction between descriptive and analytic Epidemiology, and their utility in surveillance and outbreak investigations Recognize descriptive and analytic measures used in the Epidemiological literature Know how to interpret data analysis output for measures of association and common statistical tests

Descriptive Epidemiology:

Descriptive Epidemiology Prevalence and Incidence

What is Epidemiology?:

What is Epidemiology? Study of the distribution and determinants of states or events in specified populations, and the application of this study to the control of health problems Study risk associated with exposures Identify and control epidemics Monitor population rates of disease and exposure

What is Epidemiology?:

What is Epidemiology? Looking to answer the questions: Who? What? When? Where? Why? How?

Case Definition:

Case Definition A case definition is a set of standard diagnostic criteria that must be fulfilled in order to identify a person as a case of a particular disease Ensures that all persons who are counted as cases actually have the same disease Typically includes clinical criteria (lab results, symptoms, signs) and sometimes restrictions on time, place, and person

Descriptive vs. Analytic Epidemiology:

Descriptive vs. Analytic Epidemiology Descriptive Epidemiology deals with the questions: Who, What, When, and Where Analytic Epidemiology deals with the remaining questions: Why and How

Descriptive Epidemiology:

Descriptive Epidemiology Provides a systematic method for characterizing a health problem Ensures understanding of the basic dimensions of a health problem Helps identify populations at higher risk for the health problem Provides information used for allocation of resources Enables development of testable hypotheses

Descriptive Epidemiology What?:

Descriptive Epidemiology What? Addresses the question “How much?” Most basic is a simple count of cases Good for looking at the burden of disease Not useful for comparing to other groups or populations Race # of Salmonella cases Pop. size Black 119 1,450,675 White 497 5,342,532 http://www.vdh.virginia.gov/epi/Data/race03t.pdf

Prevalence:

Prevalence The number of affected persons present in the population divided by the number of people in the population # of cases Prevalence = ----------------------------------------- # of people in the population

Prevalence Example:

Prevalence Example In 1999, Virginia reported an estimated 253,040 residents over 20 years of age with diabetes. The US Census Bureau estimated that the 1999 Virginia population over 20 was 5,008,863. 253,040 Prevalence= = 0.051 5,008,863 In 1999, the prevalence of diabetes in Virginia was 5.1% Can also be expressed as 51 cases per 1,000 residents over 20 years of age

Prevalence:

Prevalence Useful for assessing the burden of disease within a population Valuable for planning Not useful for determining what caused disease

Incidence:

Incidence The number of new cases of a disease that occur during a specified period of time divided by the number of persons at risk of developing the disease during that period of time # of new cases of disease over a specific period of time Incidence = ------------------------------------------- # of persons at risk of disease over that specific period of time

Incidence Example:

Incidence Example A study in 2002 examined depression among persons with dementia. The study recruited 201 adults with dementia admitted to a long-term care facility. Of the 201, 91 had a prior diagnosis of depression. Over the first year, 7 adults developed depression. 7 Incidence = = 0.0636 110 The one year incidence of depression among adults with dementia is 6.36% Can also be expressed as 63.6 (64) cases per 1,000 persons with dementia

Incidence:

Incidence High incidence represents diseases with high occurrence; low incidence represents diseases with low occurrence Can be used to help determine the causes of disease Can be used to determine the likelihood of developing disease

Prevalence and Incidence:

Prevalence and Incidence Prevalence is a function of the incidence of disease and the duration of disease

Prevalence and Incidence:

Prevalence and Incidence Prevalence = prevalent cases

Prevalence and Incidence:

Prevalence and Incidence Old (baseline) prevalence = prevalent cases = incident cases New prevalence Incidence No cases die or recover

Prevalence and Incidence:

Prevalence and Incidence = prevalent cases = incident cases = deaths or recoveries

Time for you to try it!!!:

Time for you to try it!!!

Descriptive Epidemiology:

Descriptive Epidemiology Person, Place, Time

Descriptive Epidemiology Who? When? Where?:

Descriptive Epidemiology Who? When? Where? Related to Person, Place, and Time Person May be characterized by age, race, sex, education, occupation, or other personal variables Place May include information on home, workplace, school Time May look at time of illness onset, when exposure to risk factors occurred

Person Data:

Person Data Age and Sex are almost always used in looking at data Age data are usually grouped – intervals will depend on what type of disease / event is being looked at May be shown in tables or graphs May look at more than one type of person data at once

Data Characterized by Person:

Data Characterized by Person http://www.vahealth.org/civp/Injury%20in%20Virginia_Report_2004.pdf

Data Characterized by Person:

Data Characterized by Person http://www.vdh.virginia.gov/std/AnnualReport2003.pdf

Data Characterized by Person:

Data Characterized by Person http://www.vdh.virginia.gov/epi/cancer/Report99.pdf

Data Characterized by Person:

Data Characterized by Person http://www.vahealth.org/chronic/Data_Report_Part_3.pdf

Time Data:

Time Data Usually shown as a graph Number / rate of cases on vertical (y) axis Time periods on horizontal (x) axis Time period will depend on what is being described Used to show trends, seasonality, day of week / time of day, epidemic period

Data Characterized by Time:

Data Characterized by Time http://www.dhhs.state.nc.us/docs/ecoli.htm

Data Characterized by Time:

Data Characterized by Time http://www.vdh.virginia.gov/std/HIVSTDTrends.pdf

Data Characterized by Time:

Data Characterized by Time http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5153a1.htm

Data Characterized by Time:

Data Characterized by Time http://www.health.qld.gov.au/phs/Documents/cdu/12776.pdf

Place Data:

Place Data Can be shown in a table; usually better presented pictorially in a map Two main types of maps used: choropleth and spot Choropleth maps use different shadings/colors to indicate the count / rate of cases in an area Spot maps show location of individual cases

Data Characterized by Place:

Data Characterized by Place http://www.vdh.virginia.gov/epi/Data/region03t.pdf

Data Characterized by Place:

Data Characterized by Place http://www.vdh.virginia.gov/epi/Data/Maps2002.pdf

Data Characterized by Place:

Data Characterized by Place http://www.vahealth.org/civp/preventsuicideva/epiplan%202004.pdf

Data Characterized by Place:

Data Characterized by Place http://www.vahealth.org/civp/preventsuicideva/epiplan%202004.pdf

Data Characterized by Place:

Data Characterized by Place Source: Olsen, S.J. et al. N Engl J Med. 2003 Dec 18; 349(25):2381-2.

5 Minute Break:

5 Minute Break

Analytic Epidemiology:

Analytic Epidemiology Hypotheses and Study Designs

Descriptive vs. Analytic Epidemiology:

Descriptive vs. Analytic Epidemiology Descriptive Epidemiology deals with the questions: Who, What, When, and Where Analytic Epidemiology deals with the remaining questions: Why and How

Analytic Epidemiology:

Analytic Epidemiology Used to help identify the cause of disease Typically involves designing a study to test hypotheses developed using descriptive epidemiology

Slide 52:

Borgman, J (1997). The Cincinnati Enquirer. King Features Syndicate.

Exposure and Outcome:

Exposure and Outcome A study considers two main factors: exposure and outcome Exposure refers to factors that might influence one’s risk of disease Outcome refers to case definitions

Case Definition:

Case Definition A set of standard diagnostic criteria that must be fulfilled in order to identify a person as a case of a particular disease Ensures that all persons who are counted as cases actually have the same disease Typically includes clinical criteria (lab results, symptoms, signs) and sometimes restrictions on time, place, and person

Developing Hypotheses:

Developing Hypotheses A hypothesis is an educated guess about an association that is testable in a scientific investigation Descriptive data provide information to develop hypotheses Hypotheses tend to be broad initially and are then refined to have a narrower focus

Example:

Example Hypothesis : People who ate at the church picnic were more likely to become ill Exposure is eating at the church picnic Outcome is illness – this would need to be defined, for example, ill persons are those who have diarrhea and fever Hypothesis : People who ate the egg salad at the church picnic were more likely to have laboratory-confirmed Salmonella Exposure is eating egg salad at the church picnic Outcome is laboratory confirmation of Salmonella

Types of Studies:

Types of Studies Two main categories: Experimental Observational Experimental studies – exposure status is assigned Observational studies – exposure status is not assigned

Experimental Studies:

Experimental Studies Can involve individuals or communities Assignment of exposure status can be random or non-random The non-exposed group can be untreated (placebo) or given a standard treatment Most common is a randomized clinical trial

Experimental Study Examples:

Experimental Study Examples Randomized clinical trial to determine if giving magnesium sulfate to pregnant women in preterm labor decreases the risk of their babies developing cerebral palsy Randomized community trial to determine if fluoridation of the public water supply decreases dental cavities

Observational Studies:

Observational Studies Three main types: Cross-sectional study Cohort study Case-control study

Cross-Sectional Studies:

Cross-Sectional Studies Exposure and outcome status are determined at the same time Examples include: Behavioral Risk Factor Surveillance System (BRFSS) - http://www.cdc.gov/brfss/ National Health and Nutrition Surveys (NHANES) - http://www.cdc.gov/nchs/nhanes.htm Also include most opinion and political polls

Cohort Studies:

Cohort Studies Study population is grouped by exposure status Groups are then followed to determine if they develop the outcome Exposure Outcome Prospective Assessed at beginning of study Followed into the future for outcome Retrospective Assessed at some point in the past Outcome has already occurred

Cohort Studies:

Cohort Studies Disease No Disease Study Population Exposed Non-exposed No Disease Disease Exposure is self selected Follow through time

Cohort Study Examples:

Cohort Study Examples Study to determine if smokers have a higher risk of lung cancer Study to determine if children who receive influenza vaccination miss fewer days of school Study to determine if the coleslaw was the cause of a foodborne illness outbreak

Case-Control Studies:

Case-Control Studies Study population is grouped by outcome Cases are persons who have the outcome Controls are persons who do not have the outcome Past exposure status is then determined

Case-Control Studies:

Case-Control Studies Had Exposure No Exposure Study Population Cases Controls No Exposure Had Exposure

Case-Control Study Examples:

Case-Control Study Examples Study to determine an association between autism and vaccination Study to determine an association between lung cancer and radon exposure Study to determine an association between salmonella infection and eating at a fast food restaurant

Cohort versus Case-Control Study:

Cohort versus Case-Control Study

Classification of Study Designs:

Classification of Study Designs Source: Grimes DA, Schulz KF. Lancet 2002; 359: 58

Time for you to try it!!!:

Time for you to try it!!!

5 Minute Break:

5 Minute Break

Analytic Epidemiology:

Analytic Epidemiology Measures of Association and Statistical Tests

Measures of Association:

Measures of Association Assess the strength of an association between an exposure and the outcome of interest Indicate how more or less likely one is to develop disease as compared to another Two widely used measures: Relative risk (a.k.a. risk ratio, RR ) Odds ratio (a.k.a. OR )

2 x 2 Tables:

2 x 2 Tables Used to summarize counts of disease and exposure in order to do calculations of association Outcome Exposure Yes No Total Yes a b a + b No c d c + d Total a + c b + d a + b + c + d

2 x 2 Tables:

2 x 2 Tables a = number who are exposed and have the outcome b = number who are exposed and do not have the outcome c = number who are not exposed and have the outcome d = number who are not exposed and do not have the outcome *********************************************************************** a + b = total number who are exposed c + d = total number who are not exposed a + c = total number who have the outcome b + d = total number who do not have the outcome a + b + c + d = total study population

Relative Risk:

Relative Risk The relative risk is the risk of disease in the exposed group divided by the risk of disease in the non-exposed group RR is the measure used with cohort studies a a + b RR = c c + d

Relative Risk Example:

Relative Risk Example Escherichia coli ? Pink hamburger Yes No Total Yes 23 10 33 No 7 60 67 Total 30 70 100 a / ( a + c ) 23 / 33 RR = = = 6.67 c / ( c+ d ) 7 / 67

Odds Ratio:

Odds Ratio In a case-control study, the risk of disease cannot be directly calculated because the population at risk is not known OR is the measure used with case-control studies a x d OR = b x c

Odds Ratio Example:

Odds Ratio Example Autism MMR Vaccine? Yes No Total Yes 130 115 245 No 120 135 255 Total 250 250 500 a x d 130 x 135 OR = = = 1.27 b x c 115 x 120

Interpretation:

Interpretation Both the RR and OR are interpreted as follows: = 1 - indicates no association > 1 - indicates a positive association < 1 - indicates a negative association

Interpretation:

Interpretation If the RR = 5 People who were exposed are 5 times more likely to have the outcome when compared with persons who were not exposed If the RR = 0.5 People who were exposed are half as likely to have the outcome when compared with persons who were not exposed If the RR = 1 People who were exposed are no more or less likely to have the outcome when compared to persons who were not exposed

Tests of Significance:

Tests of Significance Indication of reliability of the association that was observed Answers the question “How likely is it that the observed association may be due to chance?” Two main tests: 95% Confidence Intervals (CI) p-values

95% Confidence Interval (CI):

95% Confidence Interval (CI) The 95% CI is the range of values of the measure of association (RR or OR) that has a 95% chance of containing the true RR or OR One is 95% “confident” that the true measure of association falls within this interval

95% CI Example:

95% CI Example Disease Odds Ratio 95% CI Gonorrhea 2.4 1.3 – 4.4 Trichomonas 1.9 1.3 – 2.8 Yeast 1.3 1.0 – 1.7 Other vaginitis 1.7 1.0 – 2.7 Herpes 0.9 0.5 – 1.8 Genital warts 0.4 0.2 – 1.0 Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases . Am J Epidemiol. 1993 Mar 1;137(5):577-84

Interpreting 95% Confidence Intervals:

Interpreting 95% Confidence Intervals To have a significant association between exposure and outcome, the 95% CI should not include 1.0 A 95% CI range below 1 suggests less risk of the outcome in the exposed population A 95% CI range above 1 suggests a higher risk of the outcome in the exposed population

p-values:

p-values The p-value is a measure of how likely the observed association would be to occur by chance alone, in the absence of a true association A very small p-value means that you are very unlikely to observe such a RR or OR if there was no true association A p-value of 0.05 indicates only a 5% chance that the RR or OR was observed by chance alone

p-value Example:

p-value Example Disease Odds Ratio 95% CI p-value Gonorrhea 2.4 1.3 – 4.4 0.004 Trichomonas 1.9 1.3 – 2.8 0.001 Yeast 1.3 1.0 – 1.7 0.04 Other vaginitis 1.7 1.0 – 2.7 0.04 Herpes 0.9 0.5 – 1.8 0.80 Genital warts 0.4 0.2 – 1.0 0.05 Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases . Am J Epidemiol. 1993 Mar 1;137(5):577-84

Time for you to try it!!!:

Time for you to try it!!!

Questions???:

Questions???

Epidemiology Pocket Guide: Quick Review Any Time! :

Epidemiology Pocket Guide: Quick Review Any Time! Measures of Disease Frequency Classification of Study Designs 2 x 2 Tables Measures of Association Tests of Significance http://www.vdh.virginia.gov/EPR/Training.asp

Session III Slides:

Session III Slides Following this program, please visit the Web site below to access and download a copy of today’s slides: http://www.vdh.virginia.gov/EPR/Training.asp

Site Sign-in Sheet:

Site Sign-in Sheet Please submit your site sign-in sheet to: Suzi Silverstein Director, Education and Training Emergency Preparedness & Response Programs FAX: (804) 225 - 3888

References and Resources:

References and Resources Centers for Disease Control and Prevention (1992). Principles of Epidemiology: 2 nd Edition. Public Health Practice Program Office: Atlanta, GA. Gordis, L. (2000). Epidemiology: 2 nd Edition. W.B. Saunders Company: Philadelphia, PA. Gregg, M.B. (2002). Field Epidemiology: 2 nd Edition. Oxford University Press: New York. Hennekens, C.H. and Buring, J.E. (1987). Epidemiology in Medicine. Little, Brown and Company: Boston/Toronto.

References and Resources:

References and Resources Last, J.M. (2001). A Dictionary of Epidemiology: 4 th Edition. Oxford University Press: New York. McNeill, A. (January 2002). Measuring the Occurrence of Disease: Prevalence and Incidence. Epid 160 lecture series, UNC Chapel Hill School of Public Health, Department of Epidemiology. Morton, R.F, Hebel, J.R., McCarter, R.J. (2001). A Study Guide to Epidemiology and Biostatistics: 5 th Edition. Aspen Publishers, Inc.: Gaithersburg, MD. University of North Carolina at Chapel Hill School of Public Health, Department of Epidemiology, and the Epidemiologic Research & Information Center (June 1999). ERIC Notebook . Issue 2. http://www.sph.unc.edu/courses/eric/eric_notebooks.htm

References and Resources:

References and Resources University of North Carolina at Chapel Hill School of Public Health, Department of Epidemiology, and the Epidemiologic Research & Information Center (July 1999). ERIC Notebook . Issue 3. http://www.sph.unc.edu/courses/eric/eric_notebooks.htm University of North Carolina at Chapel Hill School of Public Health, Department of Epidemiology, and the Epidemiologic Research & Information Center (September 1999). ERIC Notebook . Issue 5. http://www.sph.unc.edu/courses/eric/eric_notebooks.htm University of North Carolina at Chapel Hill School of Public Health, Department of Epidemiology (August 2000). Laboratory Instructor’s Guide: Analytic Study Designs. Epid 168 lecture series. http://www.epidemiolog.net/epid168/labs/AnalyticStudExerInstGuid2000.pdf

2005 PHIN Training Development Team:

2005 PHIN Training Development Team Pia MacDonald, PhD, MPH Director, NCCPHP Jennifer Horney, MPH Director, Training and Education, NCCPHP Kim Brunette, MPH Epidemiologist, NCCPHP Anjum Hajat, MPH Epidemiologist, NCCPHP Sarah Pfau, MPH Consultant